Tag: MRK

Celltrion shares rally in South Korea after EU OKs marketing of its COVID-19 treatment

Celltrion Inc.’s shares rallied Monday after the European Commission granted the South Korean biotech firm approval to market its COVID-19 antibody treatment. The European approval of Regdanvimab, marketed by Celltrion as Regkirona in South Korea, drop up the company’s stock price 068270, +9.13% as much as 18% to 251,000 Korean won ($212.72) after the news […]

Read More

WHO is now closely tracking a delta subvariant found in 42 countries to see if it’s more transmissible

The World Health Organization is now closely tracking a subvariant of the delta variant of the coronavirus that causes COVID-19 to evaluate whether it is more infectious than the original delta. “Epidemiological and laboratory studies are ongoing to assess if AY.4.2 confers anyadditional phenotypic impacts (e.g. a change in transmissibility or a decrease in the […]

Read More

Merck nears deal for rare-disease-drug maker Acceleron

Merck is in advanced talks to acquire Acceleron Pharma Inc., according to people familiar with the matter, in a move that would bolster the pharmaceutical giant’s rare-disease business. The deal for Acceleron, which has a market value of around $11 billion, could be announced this week, assuming talks don’t fall apart, the people said. Source […]

Read More

Opinion: A straightforward explanation why more COVID-19 vaccines can’t be produced with help from ‘dozens’ of companies

In the last few days, the question of why more drug companies haven’t been enlisted for vaccine production has come up. It’s mostly due to this tweet: The problem is, as far as I can see, this is simply wrong. There are not “dozens of other pharma companies” who “stand ready” to produce these mRNA […]

Read More